Anixa Biosciences Inc
NASDAQ:ANIX
Anixa Biosciences Inc
NASDAQ:ANIX
Price:
2.83
USD
-4.39%
Market Closed
Market Cap:
$94.5m
Balance Sheet
Balance Sheet Decomposition
Anixa Biosciences Inc
Anixa Biosciences Inc
Balance Sheet Decomposition is not available for
Anixa Biosciences Inc
Anixa Biosciences Inc
Balance Sheet
Anixa Biosciences Inc
Anixa Biosciences Inc
Currency: USD
| Oct-2002 | Oct-2003 | Oct-2004 | Oct-2005 | Oct-2006 | Oct-2007 | Oct-2008 | Oct-2009 | Oct-2010 | Oct-2011 | Oct-2012 | Oct-2013 | Oct-2014 | Oct-2015 | Oct-2016 | Oct-2017 | Oct-2018 | Oct-2019 | Oct-2020 | Oct-2021 | Oct-2022 | Oct-2023 | Oct-2024 | Oct-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
1
|
3
|
4
|
2
|
3
|
3
|
3
|
6
|
29
|
12
|
1
|
1
|
1
|
|
| Cash Equivalents |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
1
|
3
|
4
|
2
|
3
|
3
|
3
|
6
|
29
|
12
|
1
|
1
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
2
|
1
|
0
|
3
|
2
|
1
|
4
|
2
|
2
|
3
|
7
|
17
|
23
|
19
|
14
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
3
|
2
|
2
|
1
|
2
|
1
|
2
|
2
|
1
|
3
|
1
|
1
|
6
|
7
|
3
|
7
|
6
|
6
|
9
|
36
|
30
|
25
|
21
|
16
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
7
|
9
|
6
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
2
-15%
|
2
0%
|
1
-37%
|
2
+27%
|
2
+1%
|
8
+301%
|
10
+31%
|
10
+2%
|
9
-14%
|
6
-35%
|
5
-4%
|
9
+67%
|
9
+3%
|
6
-40%
|
9
+56%
|
6
-27%
|
6
-2%
|
9
+50%
|
36
+284%
|
30
-16%
|
26
-16%
|
22
-15%
|
16
-26%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
2
|
2
|
3
|
2
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
5
|
5
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-17%
|
0
+29%
|
0
-20%
|
1
+66%
|
1
+17%
|
6
+749%
|
5
-6%
|
5
+1%
|
8
+39%
|
7
-10%
|
9
+28%
|
5
-42%
|
4
-15%
|
5
+8%
|
1
-81%
|
1
+13%
|
1
+5%
|
1
-35%
|
1
+19%
|
1
+67%
|
1
-14%
|
2
+34%
|
1
-42%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
62
|
65
|
68
|
73
|
81
|
86
|
92
|
108
|
113
|
121
|
125
|
135
|
145
|
146
|
151
|
156
|
170
|
182
|
192
|
205
|
218
|
228
|
241
|
252
|
|
| Additional Paid In Capital |
64
|
66
|
69
|
73
|
81
|
86
|
109
|
116
|
120
|
125
|
128
|
135
|
149
|
151
|
152
|
164
|
175
|
187
|
200
|
240
|
247
|
252
|
260
|
267
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
17
|
5
|
4
|
5
|
6
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
2
-14%
|
2
-6%
|
1
-40%
|
1
+14%
|
1
-7%
|
2
+45%
|
4
+157%
|
5
+3%
|
1
-77%
|
1
N/A
|
3
-179%
|
4
N/A
|
5
+26%
|
1
-80%
|
8
+700%
|
5
-31%
|
5
-3%
|
9
+67%
|
35
+305%
|
29
-18%
|
24
-16%
|
20
-18%
|
15
-24%
|
|
| Total Liabilities & Equity |
3
N/A
|
2
-15%
|
2
0%
|
1
-37%
|
2
+27%
|
2
+1%
|
8
+301%
|
10
+31%
|
10
+2%
|
9
-14%
|
6
-35%
|
5
-4%
|
9
+67%
|
9
+3%
|
6
-40%
|
9
+56%
|
6
-27%
|
6
-2%
|
9
+50%
|
36
+284%
|
30
-16%
|
26
-16%
|
22
-15%
|
16
-26%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
3
|
3
|
3
|
4
|
4
|
4
|
5
|
6
|
6
|
7
|
7
|
8
|
9
|
9
|
9
|
17
|
19
|
20
|
24
|
30
|
31
|
31
|
32
|
33
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
